Inter Parfums (IPAR) Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, community ranking, institutional ownership, media sentiment, dividends, valuation and profitability.

Which has more volatility and risk, PBH or IPAR?

Prestige Consumer Healthcare has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.

Is PBH or IPAR more profitable?

Prestige Consumer Healthcare has a net margin of 18.54% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	18.54%	12.23%	6.14%
Inter Parfums	10.60%	16.34%	10.82%

Which has better valuation & earnings, PBH or IPAR?

Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.11B	3.58	$209.34M	$4.11	19.56
Inter Parfums	$1.42B	3.01	$152.65M	$4.66	28.63

Does the MarketBeat Community favor PBH or IPAR?

Prestige Consumer Healthcare received 28 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.56% of users gave Prestige Consumer Healthcare an outperform vote while only 64.75% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Prestige Consumer Healthcare	Outperform Votes 489 70.56%	Underperform Votes 204 29.44%
Inter Parfums	Outperform Votes 461 64.75%	Underperform Votes 251 35.25%

Do analysts rate PBH or IPAR?

Prestige Consumer Healthcare presently has a consensus target price of $85.25, suggesting a potential upside of 6.05%. Inter Parfums has a consensus target price of $159.75, suggesting a potential upside of 19.74%. Given Inter Parfums' stronger consensus rating and higher probable upside, analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals hold more shares of PBH or IPAR?

99.9% of Prestige Consumer Healthcare shares are held by institutional investors. Comparatively, 55.6% of Inter Parfums shares are held by institutional investors. 1.6% of Prestige Consumer Healthcare shares are held by insiders. Comparatively, 43.9% of Inter Parfums shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is PBH or IPAR a better dividend stock?

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.4%. Inter Parfums pays an annual dividend of $3.00 per share and has a dividend yield of 2.2%. Prestige Consumer Healthcare pays out 46.2% of its earnings in the form of a dividend. Inter Parfums pays out 64.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Prestige Consumer Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.

Does the media favor PBH or IPAR?

In the previous week, Inter Parfums had 1 more articles in the media than Prestige Consumer Healthcare. MarketBeat recorded 6 mentions for Inter Parfums and 5 mentions for Prestige Consumer Healthcare. Inter Parfums' average media sentiment score of 1.14 beat Prestige Consumer Healthcare's score of 1.14 indicating that Inter Parfums is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inter Parfums	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Inter Parfums beats Prestige Consumer Healthcare on 12 of the 20 factors compared between the two stocks.